These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8178311)

  • 1. In vivo effect of a thrombin-like enzyme on platelet plug formation induced in mesenteric microvessels of mice.
    Chang MC; Huang TF
    Thromb Res; 1994 Jan; 73(1):31-8. PubMed ID: 8178311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiplatelet activity of ancrod on administration to rabbits.
    Chang MC; Huang TF
    J Lab Clin Med; 1995 Apr; 125(4):508-16. PubMed ID: 7706907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Vitalmicroscopic investigations of the effects of thrombin, a snake venom enzyme and histamin effect on the mesenteric microvasculature of rabbit and cat.
    Hauck G
    Arzneimittelforschung; 1976; 26(6):1233. PubMed ID: 989428
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a thrombin-like enzyme, grambin, from the venom of Trimeresurus gramineus and its in vivo antithrombotic effect.
    Chang MC; Huang TF
    Toxicon; 1995 Aug; 33(8):1087-98. PubMed ID: 8533142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.
    Hsiao G; Yen MH; Lee YM; Sheu JR
    Br J Haematol; 2002 Jun; 117(3):699-704. PubMed ID: 12028044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
    Sheu JR; Hsiao G; Lee YM; Yen MH
    Int J Hematol; 2001 Apr; 73(3):393-8. PubMed ID: 11345210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation.
    Schumacher WA; Heran CL; Steinbacher TE
    Thromb Res; 1996 Jan; 81(2):187-94. PubMed ID: 8822133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments.
    Sheu JR; Hung WC; Wu CH; Lee YM; Yen MH
    Br J Haematol; 2000 Jul; 110(1):110-5. PubMed ID: 10930986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K; Hornberger W; Kirchengast M
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thrombotic activity of PDR, a newly synthesized L-Arg derivative, on three thrombosis models in rats.
    Tang Z; Wang Y; Xiao Y; Zhao M; Peng S
    Thromb Res; 2003 May; 110(2-3):127-33. PubMed ID: 12893027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo.
    Hsiao G; Shen MY; Lin KH; Chou CY; Tzu NH; Lin CH; Chou DS; Chen TF; Sheu JR
    Eur J Pharmacol; 2003 Apr; 465(3):281-7. PubMed ID: 12681440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.
    Sheu JR; Yen MH; Peng HC; Chang MC; Huang TF
    Eur J Pharmacol; 1995 Dec; 294(1):231-8. PubMed ID: 8788436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin.
    Krishnamurti C; Bolan C; Colleton CA; Reilly TM; Alving BM
    Blood; 1993 Dec; 82(12):3631-6. PubMed ID: 8260701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.